Bernhard Angermayr

1.8k total citations
31 papers, 1.4k citations indexed

About

Bernhard Angermayr is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Bernhard Angermayr has authored 31 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hepatology, 21 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Bernhard Angermayr's work include Liver Disease and Transplantation (26 papers), Liver Disease Diagnosis and Treatment (19 papers) and Organ Transplantation Techniques and Outcomes (14 papers). Bernhard Angermayr is often cited by papers focused on Liver Disease and Transplantation (26 papers), Liver Disease Diagnosis and Treatment (19 papers) and Organ Transplantation Techniques and Outcomes (14 papers). Bernhard Angermayr collaborates with scholars based in Austria, Spain and United States. Bernhard Angermayr's co-authors include Markus Peck‐Radosavljevic, Jaime Bosch, Juan Carlos García‐Pagán, Marc Mejías, Mercedes Fernández, Alfred Gangl, Manfred Cejna, Valentin Fuhrmann, Juan Rodés and Thomas Reiberger and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Bernhard Angermayr

28 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernhard Angermayr Austria 17 1.1k 945 645 97 75 31 1.4k
Juan Carlos Bandi Argentina 17 1.5k 1.3× 1.3k 1.4× 965 1.5× 112 1.2× 150 2.0× 46 1.7k
Adil Habib United States 6 864 0.8× 754 0.8× 507 0.8× 67 0.7× 190 2.5× 12 1.1k
Francisco Vilardell Spain 13 1.1k 1.0× 793 0.8× 687 1.1× 85 0.9× 184 2.5× 23 1.6k
Michael Schepke Germany 26 1.3k 1.2× 1.3k 1.3× 1.1k 1.7× 54 0.6× 383 5.1× 64 2.3k
Eduardo Moitinho Spain 21 2.2k 1.9× 1.9k 2.0× 1.1k 1.8× 63 0.6× 85 1.1× 30 2.3k
Diego García‐Compeán Mexico 18 481 0.4× 657 0.7× 572 0.9× 26 0.3× 83 1.1× 65 1.3k
B. Begliomini Italy 19 1.0k 0.9× 491 0.5× 1.2k 1.8× 40 0.4× 110 1.5× 55 1.7k
Carlos Terra Brazil 14 1.3k 1.1× 1.0k 1.1× 580 0.9× 303 3.1× 171 2.3× 32 1.4k
Victor W. Xia United States 21 1.1k 1.0× 592 0.6× 1.1k 1.7× 95 1.0× 124 1.7× 61 1.6k
Hubert Hetz Austria 25 536 0.5× 426 0.5× 703 1.1× 129 1.3× 283 3.8× 50 1.5k

Countries citing papers authored by Bernhard Angermayr

Since Specialization
Citations

This map shows the geographic impact of Bernhard Angermayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernhard Angermayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernhard Angermayr more than expected).

Fields of papers citing papers by Bernhard Angermayr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernhard Angermayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernhard Angermayr. The network helps show where Bernhard Angermayr may publish in the future.

Co-authorship network of co-authors of Bernhard Angermayr

This figure shows the co-authorship network connecting the top 25 collaborators of Bernhard Angermayr. A scholar is included among the top collaborators of Bernhard Angermayr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernhard Angermayr. Bernhard Angermayr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bucsics, Theresa, Maria Schoder, David Bauer, et al.. (2018). Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding – A two decades experience. PLoS ONE. 13(1). e0189414–e0189414. 20 indexed citations
2.
Bucsics, Theresa, Maria Schoder, Philipp Schwabl, et al.. (2017). Re-bleeding rates and survival after early transjugular intrahepatic portosystemic shunt (TIPS) in clinical practice. Digestive and Liver Disease. 49(12). 1360–1367. 25 indexed citations
3.
Schwabl, Philipp, B.A. Payer, Jelena Grahovac, et al.. (2014). Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats. Journal of Hepatology. 60(6). 1135–1142. 37 indexed citations
4.
Payer, B.A., Thomas Reiberger, Philipp Schwabl, et al.. (2013). 593 LENALIDOMIDE AMELIORATES THE PORTAL HYPERTENSIVE SYNDROME IN NON-CIRRHOTIC AND CIRRHOTIC PORTAL HYPERTENSIVE ANIMALS. Journal of Hepatology. 58. S242–S243. 1 indexed citations
5.
Peck‐Radosavljevic, Markus, Bernhard Angermayr, Christian Datz, et al.. (2013). Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II). Wiener klinische Wochenschrift. 125(7-8). 200–219. 44 indexed citations
6.
Reiberger, Thomas, B.A. Payer, Philipp Schwabl, et al.. (2012). Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling. Liver International. 33(4). 561–568. 14 indexed citations
7.
Fuhrmann, Valentin, Nikolaus Kneidinger, Harald Herkner, et al.. (2011). Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Medicine. 37(8). 1302–1310. 100 indexed citations
8.
Rautou, Pierre‐Emmanuel, Bernhard Angermayr, Juan Carlos García‐Pagán, et al.. (2009). Pregnancy in women with known and treated Budd–Chiari syndrome: Maternal and fetal outcomes. Journal of Hepatology. 51(1). 47–54. 48 indexed citations
9.
Fuhrmann, Valentin, Nikolaus Kneidinger, Harald Herkner, et al.. (2009). Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Medicine. 35(8). 1397–1405. 155 indexed citations
10.
Reiberger, Thomas, Bernhard Angermayr, Philipp Schwabl, et al.. (2009). Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. Journal of Hepatology. 51(5). 865–873. 86 indexed citations
11.
Angermayr, Bernhard, Thomas Reiberger, Nataliya Rohr‐Udilova, et al.. (2008). 244 ANGIOGENESIS IN PORTAL HYPERTENSIVE NAD(P)HOXIDASE-KNOCKOUT-MICE IS MEDIATED BY A DIFFERENT PATHWAY THAN IN WILDTYPE ANIMALS. Journal of Hepatology. 48. S99–S99. 1 indexed citations
12.
Angermayr, Bernhard, Angelo Luca, Franz König, et al.. (2008). Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End‐stage Liver Disease score. European Journal of Clinical Investigation. 39(1). 65–71. 15 indexed citations
13.
Angermayr, Bernhard, Mercedes Fernández, Marc Mejías, et al.. (2006). NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Gut. 56(4). 560–564. 47 indexed citations
14.
Angermayr, Bernhard, Marc Mejías, Jordi Gracia‐Sancho, et al.. (2005). Heme oxygenase attenuates oxidative stress and inflammation, and increases VEGF expression in portal hypertensive rats. Journal of Hepatology. 44(6). 1033–1039. 60 indexed citations
15.
Fernández, Mercedes, Marc Mejías, Bernhard Angermayr, et al.. (2005). Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. Journal of Hepatology. 43(1). 98–103. 153 indexed citations
16.
Angermayr, Bernhard, Manfred Cejna, F. Karnel, et al.. (2004). Transjugular intrahepatic portosystemic shunt in Vienna – A decade later. Wiener klinische Wochenschrift. 116(17-18). 608–613. 5 indexed citations
17.
Angermayr, Bernhard, et al.. (2003). Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 52(6). 879–885. 232 indexed citations
18.
Angermayr, Bernhard. (2003). Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents. Hepatology. 38(4). 1043–1050. 67 indexed citations
19.
Cejna, Manfred, Markus Peck‐Radosavljevic, Siegfried Thurnher, et al.. (2002). ePTFE-Covered Stent-Grafts for Revision of Obstructed Transjugular Intrahepatic Portosystemic Shunt. CardioVascular and Interventional Radiology. 25(5). 365–372. 36 indexed citations
20.
Cejna, Manfred, Markus Peck‐Radosavljevic, Maria Schoder, et al.. (2002). Repeat Interventions for Maintenance of Transjugular Intrahepatic Portosystemic Shunt Function in Patients with Budd-Chiari Syndrome. Journal of Vascular and Interventional Radiology. 13(2). 193–199. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan Carlos Bandi Breakdown of academic impact, for papers by Adil Habib Breakdown of academic impact, for papers by Francisco Vilardell Breakdown of academic impact, for papers by Michael Schepke Breakdown of academic impact, for papers by Eduardo Moitinho Breakdown of academic impact, for papers by Diego García‐Compeán Breakdown of academic impact, for papers by B. Begliomini Breakdown of academic impact, for papers by Carlos Terra Breakdown of academic impact, for papers by Victor W. Xia Breakdown of academic impact, for papers by Hubert Hetz
Rankless by CCL
2026